Compare United States Natural Gas Fund (UNG) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
United States Natural Gas Fund vs Zimmer Biomet Holdings Inc — how do they compare? United States Natural Gas Fund trades at $11.01 (market cap $517.27M), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 32.8× United States Natural Gas Fund's market cap, and Zimmer Biomet Holdings Inc pays a 1.08% dividend while United States Natural Gas Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold United States Natural Gas Fund for 22 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| UNG | ZBH | |
|---|---|---|
Market Cap | $517.27M | $16.95B |
Volume | 29,485,537 | 2,505,240 |
Sector | Commodities - Energy | Health |
52-Week High | $16.90 | $103.98 |
52-Week Low | $9.63 | $79.58 |
Typical Hold Time | 22 Days | 89 Days |
Enterprise Value | — | $24.02B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
UNG trades at $10.81, down 1.99% today, with a bullish technical signal from moving averages but neutral oscillators. The company reported strong net income of $65.15M for 2024 despite zero revenue, with robust cash flow from operations of $47.54M. Recent news highlights natural gas market volatility driven by record production and geopolitical tensions.
The outlook is mixed: technical momentum supports near-term upside, but fundamental concerns arise from zero revenue and negative net cash flow. Risks include commodity price sensitivity and geopolitical factors affecting natural gas markets. Analyst sentiment leans bullish on technicals but requires fundamental improvement for sustained growth.
Zimmer Biomet (ZBH) trades at $88.91, up 0.47% today, with a bearish technical signal from moving averages. The company reported Q2 2026 EPS of $2.07, beating estimates, and raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23B, though net income margin declined to 8.56%. The stock is supported by a quarterly dividend of $0.24 and a consensus price target of $103.11, suggesting potential upside.
The outlook is mixed: strong fundamentals and analyst optimism contrast with technical weakness. Investment opportunities include consistent earnings beats and dividend income, but risks involve rising debt levels and competitive pressures in the medical technology sector. The stock's current valuation at a P/E of 21.57 appears reasonable if growth continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
